ClearPoint Neuro

Timeline

1. May 12, 2025 Raise Private placement: $33.5M (initial closing, as published); deal value up to $110M (not counted as received), announced May 12, 2025. Source: SEC filing. source ↗
2. Jan 24, 2025 FDA FDA 510(k) clearance: ClearPoint System (Software Version 3.0) — K243657, Jan 24, 2025. Applicant at approval: ClearPoint Neuro, Inc. source ↗
3. Nov 13, 2024 FDA FDA De Novo grant: SmartFlow Neuro Cannula — DEN240023, Nov 13, 2024. Applicant at approval: ClearPoint Neuro, Inc. source ↗

Funding

Raised: $33.5M. Last 2 years.

• May 12, 2025 Private placement: $33.5M (initial closing, as published); deal value up to $110M (not counted as received), announced May 12, 2025. Source: SEC filing. source ↗

FDA records (last 2 years)

• Jan 24, 2025 FDA 510(k) clearance: ClearPoint System (Software Version 3.0) — K243657, Jan 24, 2025. Applicant at approval: ClearPoint Neuro, Inc. source ↗
• Nov 13, 2024 FDA De Novo grant: SmartFlow Neuro Cannula — DEN240023, Nov 13, 2024. Applicant at approval: ClearPoint Neuro, Inc. source ↗

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

• 2026-02-05 Raise Private raise (SEC Form D): $17.9M sold; issuer “ClearPoint Neuro, Inc.”. Verified from the SEC filing. SEC filing ↗